Open innovation in new drug research : the case of the Indian pharmaceutical sector
The legislative environment in India underwent changes in 2005 leading to product patentprotection for pharmaceuticals. Equipped with superior process capabilities acquired forgeneric manufacturing, the pharmaceutical sector embarked on a journey to undertake radicalinnovation. The aim of the resear...
| Main Author: | |
|---|---|
| Published: |
University of Strathclyde
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.720330 |